Copper deficiency myelopathy

283Citations
Citations of this article
209Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Acquired copper deficiency has been recognised as a rare cause of anaemia and neutropenia for over half a century. Copper deficiency myelopathy (CDM) was only described within the last decade, and represents a treatable cause of non-compressive myelopathy which closely mimics subacute combined degeneration due to vitamin B12 deficiency. Here, 55 case reports from the literature are reviewed regarding their demographics, aetiology, haematological and biochemical parameters, spinal imaging, treatment and outcome. The pathophysiology of disorders of copper metabolism is discussed. CDM most frequently presented in the fifth and sixth decades and was more common in women (F:M = 3.6:1). Risk factors included previous upper gastrointestinal surgery, zinc overload and malabsorption syndromes, all of which impair copper absorption in the upper gastrointestinal tract. No aetiology was established in 20% of cases. High zinc levels were detected in some cases not considered to have primary zinc overload, and in this situation the contribution of zinc to the copper deficiency state remained unclear. Cytopenias were found in 78%, particularly anaemia, and a myelodysplastic syndrome may have been falsely diagnosed in the past. Spinal MRI was abnormal in 47% and usually showed high T2 signal in the posterior cervical and thoracic cord. In a clinically compatible case, CDM may be suggested by the presence of one or more risk factors and/or cytopenias. Low serum copper and caeruloplasmin levels confirmed the diagnosis and, in contrast to Wilson's disease, urinary copper levels were typically low. Treatment comprised copper supplementation and modification of any risk factors, and led to haematological normalisation and neurological improvement or stabilisation. Since any neurological recovery was partial and case numbers of CDM will continue to rise with the growing use of bariatric gastrointestinal surgery, clinical vigilance will remain the key to minimising neurological sequelae. Recommendations for treatment and prevention are made. © 2010 Springer-Verlag.

References Powered by Scopus

Balancing acts: Molecular control of mammalian iron metabolism

1523Citations
N/AReaders
Get full text

Copper biochemistry and molecular biology

1251Citations
N/AReaders
Get full text

Essentiality of copper in humans

922Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The essential metals for humans: a brief overview

719Citations
N/AReaders
Get full text

Dietary copper and human health: Current evidence and unresolved issues

561Citations
N/AReaders
Get full text

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

506Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jaiser, S. R., & Winston, G. P. (2010, June). Copper deficiency myelopathy. Journal of Neurology. https://doi.org/10.1007/s00415-010-5511-x

Readers over time

‘10‘11‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2507142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 56

50%

Researcher 29

26%

Professor / Associate Prof. 15

13%

Lecturer / Post doc 12

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 87

70%

Agricultural and Biological Sciences 16

13%

Neuroscience 13

10%

Chemistry 9

7%

Article Metrics

Tooltip
Mentions
Blog Mentions: 2
News Mentions: 2
References: 3
Social Media
Shares, Likes & Comments: 141

Save time finding and organizing research with Mendeley

Sign up for free
0